Institutions / Diadema Partners LP
Diadema Partners LP
CIK 2026172 · Institution · as of Dec 31, 2025
Portfolio value
$167.91M
Positions
73
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 73 →
| Company | Value | % of portfolio |
|---|---|---|
| Terns Pharmaceuticals, Inc. | $13.97M | 8.3% |
| Johnson & Johnson | $13.75M | 8.2% |
| Viking Therapeutics Inc | $11.85M | 7.1% |
| Abivax SA | $10.20M | 6.1% |
| BioMarin Pharmaceutical Inc | $8.70M | 5.2% |
| Regeneron Pharmaceuticals, Inc. | $7.95M | 4.7% |
| BridgeBio Pharma, Inc. | $5.35M | 3.2% |
| United Therapeutics Corp | $4.87M | 2.9% |
| Cogent Biosciences, Inc. | $4.68M | 2.8% |
| Capricor Therapeutics, Inc. | $4.56M | 2.7% |
| Vertex Pharmaceuticals Inc / Ma | $4.53M | 2.7% |
| Ani Pharmaceuticals Inc | $4.21M | 2.5% |
| TG Therapeutics Inc | $3.68M | 2.2% |
| BioAge Labs, Inc.BIOA | $3.59M | 2.1% |
| Corcept Therapeutics Inc | $3.39M | 2.0% |
| Tenax Therapeutics, Inc. | $2.96M | 1.8% |
| Revolution Medicines, Inc. | $2.95M | 1.8% |
| Immunocore Holdings Plc-AdrIMCR | $2.44M | 1.5% |
| Ironwood Pharmaceuticals Inc | $2.30M | 1.4% |
| Centessa Pharmaceuticals PLC | $2.25M | 1.3% |
| Replimune Group, Inc. | $2.25M | 1.3% |
| ELI LILLY & Co | $2.15M | 1.3% |
| Alnylam Pharmaceuticals Inc | $2.12M | 1.3% |
| Lipocine Inc.LPCN | $2.10M | 1.2% |
| Protagonist Therapeutics Inc | $1.98M | 1.2% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.